Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Jones Christy, a director at Beta Bionics, Inc. (NASDAQ:BBNX), executed a sale of 2,811 shares on June 4, 2026, valued at $39,354. The transaction was conducted under a Rule 10b5-1 Plan established on February 19, 2026. Post-transaction, Christy retains direct ownership of 27,400 shares. The sale occurs amidst mixed analyst sentiment following the …
MiNK Therapeutics, Inc. (NASDAQ: INKT) director Barbara Ryan completed the sale of 1,500 shares of common stock on June 4, 2026. The transaction, executed through two direct sales, generated proceeds of $19,141 at share prices between $12.6835 and $12.7995. These shares were originally granted as compensation for her board service. Following the sa…
Mark Hopman, the Chief Commercial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), executed a sale of 275 common shares on June 4, 2026. The transaction, valued at $3,385, was conducted at a per-share price of $12.31. This sale follows the terms of a Rule 10b5-1 trading plan established on May 13, 2025. Post-transaction, Hopman retains a direct stake o…
Renee Gaeta, the Chief Financial Officer of Outset Medical, Inc. (NASDAQ: OM), completed a stock transaction on June 3, 2026, selling 17,672 shares for a total value of $87,299. The transaction, executed at a price of $4.94 per share, was designated as a "sell to cover" event intended to satisfy tax withholding requirements. This activity coincides…
Antonio J Viana, a director at Arteris, Inc. (NASDAQ:AIP), executed a sale of company common stock valued at $760,879 on June 4, 2026. The transaction involved the disposal of 20,839 shares, priced between $35.4661 and $37.089 per share, conducted indirectly through the Viana Family Trust. This sale follows a 348% return over the past year and occu…
Jay A. Bys, Executive Vice President and Chief Commercial Officer at California Resources Corp, executed a pre-arranged sale of company stock valued at approximately $734,423. The transaction, conducted under a Rule 10b5-1 trading plan, occurs as the energy company reports mixed financial results for the first quarter of 2026 and advances its carbo…
Kenda B. Gonzales, a director at PERDOCEO EDUCATION Corp (NASDAQ:PRDO), executed a simultaneous exercise and sale of 9,308 common stock shares on June 4, 2026. The transaction, valued at $323,825, followed the acquisition of the same number of shares via non-qualified options. This activity occurred against a backdrop of reported strong first-quart…
Peter Graham, a member of the board of directors at Onterris, Inc. (NASDAQ:ONT), executed a direct purchase of company equity on June 3, 2026. This transaction reflects a strategic accumulation of shares by an insider as the stock experiences a notable decline over the preceding six-month period. The acquisition brings Mr. Graham's direct holding t…
James John Walker, Chief Executive Officer of Nano Nuclear Energy Inc. (NASDAQ: NNE), executed a series of transactions on June 3, 2026, disposing of approximately $3.28 million in company shares. The sales were conducted under a Rule 10b5-1 trading plan, a mechanism designed to facilitate pre-arranged stock transactions. Concurrently, Mr. Walker a…
Kristen Williams, Chief Administrative Officer at Pacira BioSciences, Inc., has completed a series of stock dispositions totaling over $418,000, according to recent Securities and Exchange Commission filings. The transactions include both voluntary sales under a Rule 10b5-1 plan and involuntary withholdings for tax obligations. These moves come as …
Kodiak Sciences Inc. (NASDAQ:KOD) Chief Financial Officer John A. Borgeson sold 30,000 shares of the company's common stock on June 4, 2026, generating $1,023,008 in proceeds. The sales were executed through a 10b5-1 trading plan established on September 29, 2025. Prior to the sale, Borgeson exercised 30,000 options at $1.04 per share, totaling $31…
Bernard Shek, serving as the Chief Legal Officer and Secretary for SanDisk Corp (NASDAQ:SNDK), completed a significant stock sale on June 3, 2026. The transaction involved the liquidation of 600 shares, generating proceeds totaling $1,041,600. This sale was executed at a price of $1,736.0 per share. The transaction was carried out in accordance wit…
Seth Jason Berl, a director at Nano Nuclear Energy Inc. (NASDAQ:NNE), executed a sale of 3,750 shares on June 5, 2026, totaling $93,458. This transaction follows a recent period of stock depreciation and occurs alongside significant corporate developments, including regulatory approvals and strategic acquisitions aimed at expanding the company's op…
Celso L Jr., Executive Vice President and Chief Financial Officer of Cleveland-Cliffs Inc. (CLF), executed a sale of 214,308 common shares on June 5, 2026, totaling $2,874,641. The transaction, conducted at prices between $13.355 and $13.48 per share, leaves Mr. Goncalves with a direct holding of 184,541.613 shares. This sale occurs against a backd…
Michael Wittmann, Chief Operating Officer at indie Semiconductor, Inc., executed a sale of 39,645 Class A Common Stock shares on June 4, 2026, generating proceeds of $190,446. The transaction, conducted at prices between $4.80 and $4.825 per share, reduces Wittmann's direct holding to 98,309 shares. This sale follows a period of significant stock d…
Quang X. Pham, serving as both Chief Executive Officer and Chairman of Cadrenal Therapeutics, Inc. (NASDAQ: CVKD), has executed a series of stock sales totaling $36,209. These transactions occurred over a three-day period from June 3 to June 5, 2026, with prices ranging between $4.26 and $4.42 per share. The sales were conducted under a Rule 10b5-1…
Farmers & Merchants Bancorp Inc. (NASDAQ:FMAO) director Andrew J. Briggs executed a sale of 3,000 shares on June 5, 2026, totaling $83,430 at a price of $27.81 per share. Following the transaction, Briggs retains a direct holding of 201,550 shares. The sale occurs as FMAO shares have gained 27% over the past year and trade near InvestingPro's fair …
ImmunityBio, Inc. (NASDAQ: IBRX) director Simon Barry J. completed a sale of 23,033 common shares on June 4, 2026, generating approximately $165,305 in proceeds. The transaction was structured under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. This sale occurs against a backdrop of substantial year-to-date stock appreciation, t…
Maya Prosor, Chief Business Officer at Lemonade, Inc. (NASDAQ:LMND), executed a sale of company equity on June 3, 2026, generating $64,867 in proceeds. The transaction involved the liquidation of 1,220 shares at $53.17 each. This disposition was necessitated by tax withholding requirements associated with the vesting and settlement of Restricted St…
Yu Jiang, President and Chairman of Nano Nuclear Energy Inc. (NASDAQ:NNE), executed a significant divestiture of common stock on June 3, 2026, selling approximately $19.9 million worth of shares. The transactions were facilitated through a Rule 10b5-1 trading plan established in September 2025. This insider activity takes place while NNE shares are…
Gen Digital Inc. (NASDAQ:GEN) director John C. Chrystal acquired 3,000 shares of the company's common stock on June 4, 2026, at a price of $27.057 per share, totaling $81,171. Following the transaction, Chrystal directly holds 31,419 shares of Gen Digital common stock. The filing also disclosed his direct ownership of 51,140 Contingent Value Rights…
John Sheldon Peters, Lemonade's Chief Insurance Officer, executed two separate sales of company stock this week totaling $283,257. The transactions occurred against a backdrop of an 11% weekly decline in Lemonade's share price, bringing the current valuation to $51.46. While the sales were driven by tax obligations and a pre-arranged trading plan, …
Timothy Bixby, Chief Financial Officer of Lemonade, Inc. (NASDAQ:LMND), executed a transaction involving the sale of 2,227 shares of the company's common stock on June 3, 2026. The transaction, valued at $118,409, involved shares sold at an average price of $53.17 each. This activity was not discretionary but was necessitated by tax withholding obl…
Jacqueline M. Welch, Executive Vice President and Chief Human Resources Officer at The New York Times Company (NYSE:NYT), sold 4,000 shares of the company’s Class A Common Stock on June 3, 2026. The transaction, valued at $296,548, occurred at prices ranging from $74.130 to $74.180 per share, with a weighted average price of $74.137. Following the …
Jaisun Garcha, Chief Financial Officer at Nano Nuclear Energy Inc. (NASDAQ: NNE), executed a series of stock sales totaling approximately $985,617 on June 3, 2026. The transactions were conducted under a Rule 10b5-1 trading plan established in September 2025, involving the disposal of 37,215 shares at prices ranging from $25.71 to $29.91. This dive…
